Skip to main content
. 2018 Aug 28;9(67):32810–32821. doi: 10.18632/oncotarget.25998

Figure 4. ROC curve analysis of urinary EV mRNA markers in various stages of bladder cancer.

Figure 4

Diagnostic performance of urinary EV SLC2A1 (purple), GPRC5A (blue) and KRT17 (green) was evaluated against that of urine cytology (ocher) and BTA ELISA assay (red) for the detection of bladder cancer at various stages. (A) all stage bladder cancer (pTa, pTis, pT1 and > pT2), (B) pTa bladder cancer, (C) pTis bladder cancer, and (D) pT1 bladder cancer. Area under the curve (AUC) of ROC curve are shown in Table 3.